Inventor · disambiguated record
Kenneth G. Draper
Also filed as: DRAPER KENNETH · DRAPER KENNETH G
44 granted patents·6 pending applications·2,367 citations·filing 1988–2003
99Inventor score
Top patents by PatentIndex Score
50 records- 0198US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 0298US5869253AMethod and reagent for inhibiting hepatitis C virus replicationRIBOZYME PHARM INC·Filed 1996·Granted Feb 9, 1999·226 cites·22 claims
- 0397US5610054AEnzymatic RNA molecule targeted against Hepatitis C virusRIBOZYME PHARM INC·Filed 1994·Granted Mar 11, 1997·165 cites·16 claims
- 0497US5248670AAntisense oligonucleotides for inhibiting herpesvirusesISIS PHARMACEUTICALS INC·Filed 1990·Granted Sep 28, 1993·140 cites·4 claims
- 0596US5004810AAntiviral oligomersSCHERING CORP·Filed 1988·Granted Apr 2, 1991·174 cites·3 claims
- 0693US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 0790US5514577AOligonucleotide therapies for modulating the effects of herpes virusesISIS PHARMACEUTICALS INC·Filed 1993·Granted May 7, 1996·153 cites·2 claims
- 0887US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 0986US5972699AMethod and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·53 cites·21 claims
- 1086US5496698AMethod of isolating ribozyme targetsRIBOZYME PHARM INC·Filed 1992·Granted Mar 5, 1996·132 cites·18 claims
- 1185US6410224B1Ribozyme treatment of diseases or conditions related to levels of NF-κBRIBOZYME PHARM INC·Filed 1996·Granted Jun 25, 2002·48 cites·4 claims
- 1285US6017756AMethod and reagent for inhibiting hepatitis B virus replicationRIBOZYME PHARM INC·Filed 1994·Granted Jan 25, 2000·79 cites·6 claims
- 1385US5731295AMethod of reducing stromelysin RNA via ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 24, 1998·59 cites·2 claims
- 1485US5693535AHIV targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·84 cites·100 claims
- 1584US5658891AOligonucleotide therapies for modulating the effects of herpesvirusesISIS PHARMACEUTICALS INC·Filed 1994·Granted Aug 19, 1997·36 cites·2 claims
- 1683US5750390AMethod and reagent for treatment of diseases caused by expression of the bcl-2 geneRIBOZYME PHARM INC·Filed 1992·Granted May 12, 1998·68 cites·13 claims
- 1783US5591720AOligonucleotides for modulating the effects of cytomegalovirus infectionsISIS PHARMACEUTICALS INC·Filed 1991·Granted Jan 7, 1997·83 cites·2 claims
- 1880US5442049AOligonucleotides for modulating the effects of cytomegalovirus infectionsISIS PHARMACEUTICALS INC·Filed 1993·Granted Aug 15, 1995·57 cites·1 claims
- 1978US6440719B1Method and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 2000·Granted Aug 27, 2002·3 cites·11 claims
- 2075US5616490ARibozymes targeted to TNF-α RNARIBOZYME PHARM INC·Filed 1995·Granted Apr 1, 1997·32 cites·8 claims
- 2174US6436644B1Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)RIBOZYME PHARM INC·Filed 2000·Granted Aug 20, 2002·2 cites·19 claims
- 2273US5639655APML-RARA targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Jun 17, 1997·34 cites·9 claims
- 2372US5693532ARespiratory syncytial virus ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·39 cites·14 claims
- 2471US6132966AMethod and reagent for inhibiting hepatitis C virus replicationRIBOZYME PHARM INC·Filed 1998·Granted Oct 17, 2000·20 cites·29 claims
- 2570US5595978AComposition and method for treatment of CMV retinitesISIS PHARMACEUTICALS INC·Filed 1994·Granted Jan 21, 1997·31 cites·9 claims
- 2668US5837542AIntercellular adhesion molecule-1 (ICAM-1) ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Nov 17, 1998·20 cites·13 claims
- 2767US5612215AStromelysin targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 18, 1997·19 cites·166 claims
- 2866US5616488AIL-5 targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Apr 1, 1997·23 cites·22 claims
- 2965US5610052AEnzymatic RNA with activity to rasRIBOZYME PHARM INC·Filed 1992·Granted Mar 11, 1997·19 cites·12 claims
- 3065US5599704AErbB2/neu targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Feb 4, 1997·17 cites·14 claims
- 3162US5658780ARel a targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Aug 19, 1997·14 cites·13 claims
- 3262US5622854AMethod and reagent for inhibiting T-cell leukemia virus replicationRIBOZYME PHARM INC·Filed 1994·Granted Apr 22, 1997·19 cites·11 claims
- 3360US6310044B1Oligonucleotide therapies for modulating the effects of herpesvirusesISIS PHARMACEUTICALS INC·Filed 1991·Granted Oct 30, 2001·10 cites·10 claims
- 3458US5817796AC-myb ribozymes having 2'-5'-linked adenylate residuesFiled 1995·Granted Oct 6, 1998·10 cites·3 claims
- 3557US6258585B1Method and reagent for inhibiting influenza virus replicationRIBOZYME PHARM INC·Filed 1994·Granted Jul 10, 2001·14 cites·8 claims
- 3657US6159692AMethod and reagent for inhibiting human immunodeficiency virus replicationRIBOZYME PHARM INC·Filed 1999·Granted Dec 12, 2000·8 cites·27 claims
- 3757US2004033568A9Method and reagent for treatment of diseases caused by expression of the c-myc geneRIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 3857US2003003469A1Ribozyme treatment of diseases or conditions related to levels of NF-kappaBRIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 3955US5801158AEnzymatic RNA with activity to RASRIBOZYME PHARM INC·Filed 1996·Granted Sep 1, 1998·8 cites·22 claims
- 4049US6153595AComposition and method for treatment of CMV infectionsISIS PHARMACEUTICALS INC·Filed 1997·Granted Nov 28, 2000·8 cites·21 claims
- 4149US5795778AMethod and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 1996·Granted Aug 18, 1998·6 cites·10 claims
- 4249US2004054156A1Method and reagent for inhibiting hepatitis B viral replicationFiled 2003·Application pending·0 cites
- 4348US5767102AAntisense composition and method for treatment of CMV infectionISIS PHARMACEUTICALS INC·Filed 1997·Granted Jun 16, 1998·7 cites·4 claims
- 4447US2004127446A1Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replicationFiled 2003·Application pending·0 cites
- 4545US6432704B1Method and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 1999·Granted Aug 13, 2002·3 cites·11 claims
- 4645US2002177568A1Enzymatic nucleic acid treatment of diseases or conditions related to levels of NF-kappa BFiled 2001·Application pending·0 cites
- 4744US2003068301A1Method and reagent for inhibiting hepatitis B virus replicationFiled 2001·Application pending·0 cites
- 4840US6132967ARibozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)RIBOZYME PHARM INC·Filed 1998·Granted Oct 17, 2000·2 cites·24 claims
- 4936US6544755B1Method and reagent for treatment of diseases by expression of the c-Myc geneRIBOZYME PHARM INC·Filed 1994·Granted Apr 8, 2003·2 cites·8 claims
- 5033US6492512B1Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expressionRIBOZYME PHARM INC·Filed 1992·Granted Dec 10, 2002·1 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Kenneth G. Draper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →